Today: 15 May 2026
Alphabet slips as year-end tech rally pauses; Fed minutes loom
29 December 2025
2 mins read

Alphabet slips as year-end tech rally pauses; Fed minutes loom

NEW YORK, December 29, 2025, 10:06 ET — Regular session

  • Alphabet’s Class C shares fell about 0.7% in early trading, tracking a pullback in heavyweight tech
  • Traders are watching Tuesday’s Federal Reserve minutes for clues on the 2026 rate path
  • Google’s Gemini Live voice mode rolled out a major update, but macro and year-end positioning set the near-term tone

Alphabet’s Class C shares (GOOG.O) fell about 0.7% to $312.80 in early Monday trading, giving back ground as U.S. tech stocks eased at the start of the final week of the year.

The move matters now because Alphabet is one of the largest U.S. companies by market value, and small swings in mega-cap tech can tug broader indexes in holiday-thinned trade. Investors have leaned heavily on AI-linked technology winners in 2025, making positioning vulnerable to profit-taking.

Rate expectations are also back in focus. Growth stocks such as Alphabet tend to be sensitive to bond yields because investors value future profits more when borrowing costs fall.

Wall Street opened lower on Monday as heavyweight technology stocks gave up some of last week’s gains, Reuters reported.

Peers were mixed. Microsoft (MSFT.O) was up about 0.1%, while Meta Platforms (META.O) fell about 0.9%.

In global markets, investors have been leaning into expectations for further U.S. rate cuts next year. “We’re not seeing runaway inflation risk as a base case so we’re still thinking the Fed has room to cut,” Fidelity International multi-asset portfolio manager Becky Qin said. Reuters

The next near-term catalyst is Tuesday’s release of the Federal Reserve’s meeting minutes — the detailed account of the central bank’s last policy meeting — scheduled for 2:00 p.m. ET on December 30.

Fed communications have been moving markets as traders price the pace of easing. Reuters reported the Fed cut its benchmark rate to a 3.5%–3.75% range this month and money markets are pricing two more quarter-point cuts by September.

On the company front, Google has kept a steady drumbeat of AI product updates. Gemini Live — the company’s voice-based, conversational mode for its Gemini assistant — received what Google described as its “biggest update ever,” making it more natural and conversational, WIRED reported. WIRED

For investors, the question is how quickly those features translate into sustained engagement and paid usage, and whether Google can protect search and advertising demand as AI features reshape how people find information.

Alphabet also remains closely watched for the balance between AI investment and profitability. In its most recent quarterly filing, Alphabet reported revenue of $102.3 billion for the third quarter, up 16% year-on-year, with double-digit growth across Search, YouTube and Cloud.

At Monday’s price, Alphabet’s market value stood at about $2.94 trillion and the stock traded at roughly 24 times earnings, a commonly used valuation gauge that compares share price to profit per share.

With few major corporate earnings on the calendar this week, investors are likely to take direction from rate signals and year-end flows into the close of 2025, alongside routine economic releases.

Traders will also be watching whether the year-end dip in liquidity amplifies index moves. In that setup, Alphabet’s next decisive catalysts — ad trends, cloud momentum and the pace of AI-related spending — shift into early 2026.

Stock Market Today

  • ABIVAX Société Anonyme Stock Slides Amid High Valuation and Losses
    May 15, 2026, 12:02 AM EDT. ABIVAX Société Anonyme (ENXTPA:ABVX) saw its stock fall 1.3% over one day, down 3.9% over a week, prompting investor scrutiny. Despite 55.4% revenue growth, the company posted a net loss of €336 million and trades at a price-to-book (P/B) ratio of 18x, compared with the French biotech average of 4.6x. The elevated P/B suggests expectations for future growth rather than current earnings, as ABIVAX remains unprofitable and relies on external borrowing. Analysts note shares trade 86% below fair value estimates based on projected cash flows, but high losses and negative return on equity (73.84%) weigh on sentiment. The stock's premium valuation reflects bullish views on drug pipeline progress, though risks remain amid ongoing clinical trials.

Latest articles

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 15.05.2026

15 May 2026
LIVEMarkets rolling coverageStarted: May 15, 2026, 12:00 AM EDTUpdated: May 15, 2026, 12:11 AM EDT ABIVAX Société Anonyme Stock Slides Amid High Valuation and Losses May 15, 2026, 12:02 AM EDT. ABIVAX Société Anonyme (ENXTPA:ABVX) saw its stock fall 1.3% over one day, down 3.9% over a week, prompting investor scrutiny. Despite 55.4% revenue growth, the company posted a net loss of €336 million and trades at a price-to-book (P/B) ratio of 18x, compared with the French biotech average of 4.6x. The elevated P/B suggests expectations for future growth rather than current earnings, as ABIVAX remains unprofitable and relies on
US Stock Market Today After Hours: Why the Dow Reclaimed 50,000 as AI Stocks Drove Wall Street Higher

US Stock Market Today After Hours: Why the Dow Reclaimed 50,000 as AI Stocks Drove Wall Street Higher

15 May 2026
The Dow closed above 50,000 for the first time Thursday, rising 370 points as AI-driven gains lifted U.S. stocks to record highs. Cisco surged after raising its revenue outlook and announcing $9 billion in AI infrastructure orders, while Nvidia jumped 4.4% on U.S. approval to sell chips to China. Cerebras Systems soared 68% in its market debut. Not all chipmakers advanced, with Qualcomm, Intel, Sandisk, and Micron falling sharply.
Xanadu Quantum Technologies Stock Gets Its First Public Earnings Test—and Losses Still Rule

Xanadu Quantum Technologies Stock Gets Its First Public Earnings Test—and Losses Still Rule

15 May 2026
Xanadu Quantum Technologies reported first-quarter revenue of $2.8 million, up from $0.7 million a year earlier, but net loss widened to $20.6 million. Shares rose 1.9% to $15.13 in late U.S. trading before falling over 3% after hours. The company ended March with $272.5 million in cash and plans a $300 million at-the-market facility. Xanadu began trading on Nasdaq and TSX under XNDU on March 27.
Sidus Space Stock Jumps After Q1 Revenue Rises 51%, But Losses Still Loom

Sidus Space Stock Jumps After Q1 Revenue Rises 51%, But Losses Still Loom

15 May 2026
Sidus Space reported first-quarter revenue of $359,000, up 51% from a year earlier, and a net loss of $5.2 million, narrowing from $6.4 million. Shares rose about 12% after results. Cash stood at $27.3 million at March 31, down from $43.2 million at year-end. The company raised $58.5 million in a direct share offering after the quarter closed.
Microsoft stock dips as Wall Street’s year-end rally pauses, Fed minutes loom
Previous Story

Microsoft stock dips as Wall Street’s year-end rally pauses, Fed minutes loom

Pfizer filings spotlight big portfolio shifts as Live Oak slashes stake 92%
Next Story

Pfizer filings spotlight big portfolio shifts as Live Oak slashes stake 92%

Go toTop